Position in RPRX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$16,015,274
+$1,963,854 QoQ
Shares Held
285,630
-2.5% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#119
of 641 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Derivatives in RPRX
reported options exposure · as of Jun 30, 2024CallValue
$779
CallShares
5,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. RPRX ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
870,551 | $82,484,707 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
64,650 | $40,311,861 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
105,045 | $31,621,696 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,020 | $24,349,704 | |
| 5 | RPRX |
Royalty Pharma plc
This page
|
285,630 | $16,015,274 | |
| 6 | EXEL |
Exelixis, Inc.
|
291,162 | $15,842,124 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
56,313 | $13,783,733 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
140,394 | $11,443,514 |
All Filings in RPRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,015,274 | 285,630 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $14,051,420 | 292,921 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $10,862,554 | 281,122 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $7,760,047 | 219,956 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $7,426,287 | 206,114 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $5,335,495 | 171,394 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,423,714 | 173,411 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $5,165,414 | 182,588 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $779 | 5,000 | Call | Sole | 2024-08-13 | |
| 2024-06-30 | $5,174,110 | 196,212 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,625 | 5,000 | Call | Sole | 2024-05-06 | |
| 2024-03-31 | $6,815,756 | 224,424 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $4,926,873 | 175,396 | Shares | Sole | 2024-02-12 | |
| 2023-12-31 | $1,125 | 5,000 | Put | Sole | 2024-02-12 | |
| 2023-09-30 | $2 | 10 | Put | Sole | 2023-11-08 | |
| 2023-09-30 | $6,273,248 | 231,144 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,688 | 120 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $4,968,106 | 161,617 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,911,478 | 164,071 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,281,822 | 158,953 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $6,742,244 | 167,801 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $7,021,058 | 167,009 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $5,910,465 | 151,706 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $5,231,348 | 131,276 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,351,798 | 120,415 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,853,502 | 118,407 | Shares | Sole | 2021-08-06 | |
| No filing history on record for this holder in this stock. | ||||||